Deciphering the Mechanisms of Multiple Myeloma Tumor Driving Factor Whsc1 in Kras Mutated Colon Cancer Progression and Investigate the Whsc1 Targeting Combination Therapy

Medicine & Life Sciences

1. Colonic Neoplasms 100%
2. Fluorouracil 18%
3. Oxaliplatin 15%
4. Multiple Myeloma 12%
5. Drug Resistance 11%
6. Carcinogenesis 9%
7. Therapeutics 9%
8. Clustered Regularly Interspaced Short Palindromic Repeats 7%
9. Preliminary Data 7%
10. Epithelial-Mesenchymal Transition 6%
11. Microarray Analysis 6%
12. Neoplasms 6%
13. Disease Progression 5%